recombinant protein technology (Proteintech)
Proteintech is a verified supplier 
94
Structured Review
Proteintech
recombinant protein technology
Recombinant Protein Technology, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+technology/Animal-free+Recombinant+Human+FGF-4/pmc12915835-77-23-24
Average 94 stars, based on 9 article reviews
Recombinant Protein Technology, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+protein+technology/Animal-free+Recombinant+Human+FGF-4/pmc12915835-77-23-24
Average 94 stars, based on 9 article reviews
recombinant protein technology - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Recombinant:Article Title: The production of recombinant platelet-derived growth factor D using the second generation modified vaccinia Ankara viral system. Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense in surrounding stromal cells, thereby mediating cell–cell interactions.12 The involvement of the PDGF family in a myriad of physiological and pathological processes including organ development, angiogenesis, bone remodeling, cardiovascular disease, inflammatory responses, and cancer provides a great impetus for producing recombinant proteins of these ligands to permit scientists to study the mechanisms of PDGF biology and to test their therapeutic efficacies.13–15 The classic PDGF ligands, PDGF A and B, are secreted as active homodimeric or heterodimeric ligands.4 Advancement in Article Title: Industry News Article Snippet: Australia-based biotechnology company, Benitec, has started its first HIV human clinical trial in a biomedical research and treatment center located in USA.. City of Hope, the medical center that the trial is taking place, is situated near Los Angeles, USA.. This trial will involve five HIV-1 infected adults 18–60 years old who suffer from AIDS-related lymphoma. Article Title: Unleashing the potential of natural protein based nanoparticles for the delivery of therapeutic nucleic Acid: A comprehensive review. Article Snippet: Nucleic acid-based therapeutics represent a revolutionary approach in treating genetic disorders, offering unprecedented potential for addressing pathologies at their molecular level.. However, effective cellular delivery remains a critical challenge hindering their clinical implementation.. While existing delivery systems, including viral vectors and lipid nanoparticles, have shown utility, they face limitations in immunogenicity, cargo capacity, and manufacturing complexity. Article Title: Enzyme redundancy and the importance of 2-oxoglutarate in plant ammonium assimilation. Article Snippet: Ammonium is the reduced nitrogen form available to plants for assimilation into amino acids.. This is achieved by the GSuGOGAT pathway that requires carbon skeletons in the form of 2-oxoglutarate.. To date, the exact enzymatic origin of this organic acid for plant ammonium assimilation is unknown. Article Title: Decarbonizing the Food System with Microbes and Carbon-Neutral Feedstocks. Article Snippet: Harnessing CO2 and CO2-derived C1–C2 compounds for microbial food production can mitigate greenhouse gas emissions and boost sustainability within the food sector.. These innovative technologies support carbon neutrality by generating nutrient-rich edible microbial biomass and biocompounds using autotrophic and heterotrophic microbes.. However, qualifying microbial food viability and future impacts in the food sector remains challenging due to their diversity, technical complexity, socioeconomic forces, and incipient markets. Article Title: Staufen dsRNA-binding domain as modules to design bifunctional antibodies for siRNA delivery Article Snippet: .. The relevant domains were cloned, expressed, and purified using the Article Title: Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study Article Snippet: .. Currently, the majority of influenza vaccines are manufactured using egg production platforms, with a smaller proportion produced in mammalian cell culture or using Sequencing:Article Title: The production of recombinant platelet-derived growth factor D using the second generation modified vaccinia Ankara viral system. Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense in surrounding stromal cells, thereby mediating cell–cell interactions.12 The involvement of the PDGF family in a myriad of physiological and pathological processes including organ development, angiogenesis, bone remodeling, cardiovascular disease, inflammatory responses, and cancer provides a great impetus for producing recombinant proteins of these ligands to permit scientists to study the mechanisms of PDGF biology and to test their therapeutic efficacies.13–15 The classic PDGF ligands, PDGF A and B, are secreted as active homodimeric or heterodimeric ligands.4 Advancement in Article Title: Enzyme redundancy and the importance of 2-oxoglutarate in plant ammonium assimilation. Article Snippet: Ammonium is the reduced nitrogen form available to plants for assimilation into amino acids.. This is achieved by the GSuGOGAT pathway that requires carbon skeletons in the form of 2-oxoglutarate.. To date, the exact enzymatic origin of this organic acid for plant ammonium assimilation is unknown. Modification:Article Title: Unleashing the potential of natural protein based nanoparticles for the delivery of therapeutic nucleic Acid: A comprehensive review. Article Snippet: Nucleic acid-based therapeutics represent a revolutionary approach in treating genetic disorders, offering unprecedented potential for addressing pathologies at their molecular level.. However, effective cellular delivery remains a critical challenge hindering their clinical implementation.. While existing delivery systems, including viral vectors and lipid nanoparticles, have shown utility, they face limitations in immunogenicity, cargo capacity, and manufacturing complexity. Derivative Assay:Article Title: Unleashing the potential of natural protein based nanoparticles for the delivery of therapeutic nucleic Acid: A comprehensive review. Article Snippet: Nucleic acid-based therapeutics represent a revolutionary approach in treating genetic disorders, offering unprecedented potential for addressing pathologies at their molecular level.. However, effective cellular delivery remains a critical challenge hindering their clinical implementation.. While existing delivery systems, including viral vectors and lipid nanoparticles, have shown utility, they face limitations in immunogenicity, cargo capacity, and manufacturing complexity. Control:Article Title: Unleashing the potential of natural protein based nanoparticles for the delivery of therapeutic nucleic Acid: A comprehensive review. Article Snippet: Nucleic acid-based therapeutics represent a revolutionary approach in treating genetic disorders, offering unprecedented potential for addressing pathologies at their molecular level.. However, effective cellular delivery remains a critical challenge hindering their clinical implementation.. While existing delivery systems, including viral vectors and lipid nanoparticles, have shown utility, they face limitations in immunogenicity, cargo capacity, and manufacturing complexity. Polymer:Article Title: Unleashing the potential of natural protein based nanoparticles for the delivery of therapeutic nucleic Acid: A comprehensive review. Article Snippet: Nucleic acid-based therapeutics represent a revolutionary approach in treating genetic disorders, offering unprecedented potential for addressing pathologies at their molecular level.. However, effective cellular delivery remains a critical challenge hindering their clinical implementation.. While existing delivery systems, including viral vectors and lipid nanoparticles, have shown utility, they face limitations in immunogenicity, cargo capacity, and manufacturing complexity. Activity Assay:Article Title: Enzyme redundancy and the importance of 2-oxoglutarate in plant ammonium assimilation. Article Snippet: Ammonium is the reduced nitrogen form available to plants for assimilation into amino acids.. This is achieved by the GSuGOGAT pathway that requires carbon skeletons in the form of 2-oxoglutarate.. To date, the exact enzymatic origin of this organic acid for plant ammonium assimilation is unknown. Clone Assay:Article Title: Staufen dsRNA-binding domain as modules to design bifunctional antibodies for siRNA delivery Article Snippet: .. The relevant domains were cloned, expressed, and purified using the Purification:Article Title: Staufen dsRNA-binding domain as modules to design bifunctional antibodies for siRNA delivery Article Snippet: .. The relevant domains were cloned, expressed, and purified using the Vaccines:Article Title: Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study Article Snippet: .. Currently, the majority of influenza vaccines are manufactured using egg production platforms, with a smaller proportion produced in mammalian cell culture or using Produced:Article Title: Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study Article Snippet: .. Currently, the majority of influenza vaccines are manufactured using egg production platforms, with a smaller proportion produced in mammalian cell culture or using Cell Culture:Article Title: Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study Article Snippet: .. Currently, the majority of influenza vaccines are manufactured using egg production platforms, with a smaller proportion produced in mammalian cell culture or using |